- Global Pharma News & Resources

Surgical Stapling Devices Market is anticipated to reach US$ 6.2 billion by 2031, at a CAGR of 8.4%

According to Future Market Insights, global Surgical Stapling Devices Market demand is increasing in tandem with the world’s ageing population. Surgical Stapling Devices take less time to close wounds, and their accuracy and precision make them ideal for healing wounds in elderly patients. The global Surgical Stapling Devices Market was valued at US$ 2.9 billion in 2022 and is expected to reach US$ 6.2 billion by 2031, according to Future Market Insights (FMI).

A sample of this report is available upon request@

Medical practitioners will continue to embrace specialised equipment that facilitate certain surgical operations in medical procedures as advanced technologies are deployed. The increasing incidence of invasive procedures has demanded the development of improved wound management devices. Furthermore, surgical staples have efficiently replaced sutures for wound closure during such surgeries.

Future Market Insights recently produced a research on the global market for Surgical Stapling Devices, the highlights of which show that an increase in the number of laparoscopic procedures conducted around the world has prompted the adoption of Surgical Stapling Devices.

In the report, titled “Surgical Stapling Devices Market: Global Industry Analysis and Opportunity Assessment, 2022 to 2031,” North America has been identified as the largest market for Surgical Stapling Devices. By the end of forecast period, more than US$ 1,000 Million revenues will be solely attributed by North America’s Surgical Stapling Devices market.

Western Europe’s advanced healthcare infrastructure has helped the region’s Surgical Stapling Devices market, which will grow at a 7.9% CAGR through 2031. However, the Asia-Pacific excluding Japan (APEJ) region will have the highest consumption of Surgical Stapling Devices. The APEJ Surgical Stapling Devices market is predicted to grow at the fastest rate, with a CAGR of 8.6%.

According to the report, hospitals will continue to be the world’s leading end-users of Surgical Stapling Devices, accounting for more than 60% of global revenues. Meanwhile, ambulatory surgical centres will see an increase in demand for surgical stapling instruments. The report’s key findings show that powered Surgical Stapling Devices worth US$ 1,182 million were sold globally in 2022, while demand for manual surgical stapling items is expected to decline in the coming years.

Ask Our Analyst More About Report@

Throughout the forecast period, six out of ten Surgical Stapling Devices sold in the world are likely to be disposable, while revenues from reusable surgical stapling products will be growing at a sluggish rate. Preference to curved surgical stapling is also on a rise, revenues from which are expected to soar impressively at 9% CAGR.

Dermatological surgeries will undoubtedly require greater number of Surgical Stapling Devices. The report estimates that in 2022, nearly US$ 600 million revenues were amassed from the sales of Surgical Stapling Devices in treatment of skin-related surgical wounds. The use of advanced Surgical Stapling Devices is also expected to gain momentum for closing dissected or ruptured blood vessels during surgeries. Wounds situated in the patient’s digestive tract are also being treated by surgical stapling, and by the end of 2031, around US$ 665 million worth of devices will be consumed for such treatments.

Competitive Landscape:

Companies operating in the Surgical Stapling Devices market is competitive by nature, with a few number of global and local competitors.

Leading Manufacturers of Surgical Stapling Devices: Medtronic plc, Grena Ltd., Purple Surgical Holdings Limited, Dextera Surgical Inc., Johnson & Johnson Services, Inc., 3M Company, and Meril Life Sciences Pvt. Ltd.

Key players in global Surgical Stapling Devices market are focusing on tapping the emerging markets in order to increase market share and increase the consumer base through exclusive product launch and approval in the emerging market. Some of the recent instances include:

  • Medtronic plc announced in October 2021 that it had gained the CE (Conformité Européenne) Certification for the HugoTM robotic-assisted surgery (RAS) system, allowing it to be sold in Europe. CE Mark clearance is only available for urologic and gynecologic operations, which account for almost half of all robotic procedures performed today.
  • PREVENA RESTOR AXIO•FORMTM Incision Management System, developed to maintain post-operative incisions as well as the surrounding soft tissue envelope following orthopaedic surgical repair of lower extremity fractures, will be available in October 2020, according to 3M.

More Insights Available:

The global surgical stapling products market has been growing steadily in recent years, driven by the increasing adoption of minimally invasive surgical procedures and the growing demand for Surgical Stapling Devices in emerging economies. The market is also benefiting from the development of advanced stapling technologies that offer greater precision and improved patient outcomes.

Buy Complete Report@

Surgical Stapling Devices Market by Category

By Product:

  • Powered Surgical Stapling Device
  • Manual Surgical Stapling Device

By Usage:

  • Disposable Surgical Stapling Device
  • Reusable Surgical Stapling Device

By Stapling Type:

  • Straight
  • Curved
  • Circular

By Indication:

  • Skin
  • Digestive Tract
  • Blood Vessels
  • Hernia
  • Lung
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 30-May-2023